Seeing Is Believing
CTi Biopharma Corp's activity chart (see below) currently has 39 price targets and 38 ratings on display.
Analysts average stock forecasts to be materialized ratio is 81.93% with an average time for these price targets to be met of 475.76 days.
Most recent stock forecast was given by from JMP on 24-May-2023. First documented stock forecast 09-Sep-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-May-2023
3 years 4 months 1 days ago
(24-May-2023)
4/4 (100%)
$4.25 (89.47%)
144
Buy Since 17-Oct-2022
$9.1
$0.01 (0.11%)
$13
3 years 4 months 9 days ago
(16-May-2023)
1/2 (50%)
$0.19 (2.13%)
36
Buy Since 06-May-2021
$9.1
$0.01 (0.11%)
$8.1
3 years 4 months 10 days ago
(15-May-2023)
5/5 (100%)
$0.17 (1.90%)
108
Buy Since 02-Dec-2021
$9
3 years 4 months 14 days ago
(11-May-2023)
7/7 (100%)
$3.88 (75.78%)
236
Buy Since 13-Oct-2020
$9.1
$0.01 (0.11%)
$8
3 years 4 months 15 days ago
(10-May-2023)
2/2 (100%)
$0.17 (1.90%)
491
What is CTIC (CTi Biopharma Corp) average time for price targets to be met?
Which analyst most recently updated their price target on CTIC (CTi Biopharma Corp)?
Which analyst has the most public recommendations on CTIC (CTi Biopharma Corp)?
Which analyst is the currently most bullish on CTIC (CTi Biopharma Corp)?
Which analyst is the currently most reserved on CTIC (CTi Biopharma Corp)?